Eli Lilly & Co., US5324571083

Lam Research stock holds after fiscal 2025 revenue and margin gains

Published on 07/23/2026 at 13:53 | Editorial responsibility: Rafael Müller, Editor-in-Chief AD HOC NEWS

Lam Research stock is supported by fiscal 2025 revenue of $17.1 billion and non-GAAP gross margin of 49.6%, with net income reaching $5.4 billion.

Schwarz-Weiß-Reportagefoto eines Reinraum-Technikers im weißen Bunny-Suit, der einen Wafer-Carrier vor Maschinenreihen hält
Lam Research US5324571083 Reinraum Techniker haelt Wafer Carrier im Schwarz Weiss Reportage Stil, Illustration mit AI erstellt.

Lam Research (ISIN US5324571083) stock is anchored by fiscal 2025 revenue of $17.1 billion, non-GAAP gross margin of 49.6%, and net income of $5.4 billion, according to the company’s investor relations context. The latest published figures also show fiscal 2025 operating cash flow of $5.6 billion, which gives the chip tools group a clear earnings and cash-generation base.

Revenue at $17.1 billion

For fiscal 2025, Lam Research reported $17.1 billion in revenue, up from $14.9 billion in fiscal 2024, a year-over-year increase of about 14.8%. Non-GAAP gross margin widened to 49.6% from 47.2% a year earlier, while non-GAAP operating margin improved to 31.9% from 28.6%.

That mix matters because Lam Research sells wafer fabrication equipment into memory and logic spending cycles, where margin discipline can offset swings in quarterly demand. Fiscal 2025 operating cash flow of $5.6 billion and free cash flow of $4.8 billion also show the company converting sales into liquidity at scale.

Cash flow stayed strong

Lam Research ended fiscal 2025 with $6.5 billion in cash and cash equivalents and $14.9 billion in debt, leaving a balance sheet that remains highly geared but still liquid. Net income rose to $5.4 billion from $4.1 billion in fiscal 2024, an increase of roughly 31.7%.

Those numbers frame the stock more as a cash-flow and cycle story than a simple top-line call. The gap between revenue growth and profit growth suggests that pricing, mix, and cost control all moved in the same direction during the year.

Chip tools still drive results

Lam Research’s core etch and deposition tools remain the product engine behind the financial profile, with the company serving wafer fabrication customers that need advanced process control for memory and leading-edge logic. The annual report context highlights that demand is still tied to customer investment cycles rather than consumer end-demand.

For investors, the key point is that fiscal 2025 already provides three useful reference lines: $17.1 billion in revenue, $5.4 billion in net income, and 49.6% non-GAAP gross margin. The comparison with fiscal 2024 shows the business improved on both scale and profitability at the same time.

Fiscal 2025 closes the loop

The stock closes the picture with a market lens: Lam Research shares are tied to a company that produced $5.6 billion in operating cash flow in fiscal 2025 and $4.8 billion in free cash flow over the same period. That leaves the equity story closely linked to future equipment cycles, not just one quarter of orders.

Lam Research stock therefore reads as a balance-sheet-and-margin story first, with annual report momentum doing most of the work in the current setup.

Lam Research key facts

  • Company: Lam Research Corporation
  • ISIN: US5324571083
  • Ticker: NASDAQ: LRCX
  • Trading venue: NASDAQ
  • Sector / Industry: Information Technology / Semiconductors
  • Index membership: Nasdaq 100, S&P 500

Disclaimer regarding our articles: No investment advice, no buy or sell recommendation. Information on prices, companies, and markets is provided without guarantee; changes are possible at any time. Stock market transactions can lead to substantial losses. Our articles are created and reviewed in whole or in part automatically with the support of AI.

en | US5324571083 | ELI LILLY & CO. | boerse | 69851389 | bgmi